Cardiovascular safety of COX-2 inhibition: Time to inform systems of postmarketing surveillance?

Robert J. MacFadyen, Thomas M. MacDonald

Research output: Contribution to journal › Editorial

86 Downloads (Pure)

Cite this

@article{92e82f0aad0f497b80949f8226caaeee,

title = "Cardiovascular safety of COX-2 inhibition: Time to inform systems of postmarketing surveillance?",

author = "MacFadyen, {Robert J.} and MacDonald, {Thomas M.}",

year = "2005",

month = may,

language = "English",

volume = "2",

pages = "325--328",

journal = "Therapy",

issn = "1475-0708",

publisher = "Future Medicine",

number = "3",

}

TY - JOUR

T1 - Cardiovascular safety of COX-2 inhibition

T2 - Time to inform systems of postmarketing surveillance?

AU - MacFadyen, Robert J.

AU - MacDonald, Thomas M.

PY - 2005/5

Y1 - 2005/5

UR - http://www.scopus.com/inward/record.url?scp=20344382269&partnerID=8YFLogxK

M3 - Editorial

AN - SCOPUS:20344382269

VL - 2

SP - 325

EP - 328

JO - Therapy

JF - Therapy

SN - 1475-0708

IS - 3

ER -